Chronic hyperglycemia and insulin resistance trigger systemic inflammation, leading to the release of pro-inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) [63]. This evidence concerns the gene IL6 and Insulin resistance.